Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Many patients with acute MI have risk factors for shock, which increase the likelihood of adverse outcomes with early initiation of beta-blocker therapy,…
NEW YORK (Reuters Health) – Ventricular pauses associated with the use of ticagrelor don’t result in clinically significant bradycardia, according to a report in the May 10th Journal…
NEW YORK (Reuters Health) – Older people with chronic obstructive pulmonary disease may live longer if started on an inhaled long-acting beta-agonist than an inhaled long-acting anticholinergic, Canadian…
Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses menopause and hormone replacement therapy. To learn more about the Women’s…
NEW YORK (Reuters Health) -In the emergency department, a standardized protocol of hydromorphone administration is more efficacious than usual care for controlling acute severe pain, a team at…
NEW YORK (Reuters Health) – A Danish observational study provides no evidence that use of angiotensin receptor blockers (ARBs) is associated with an increased risk of incident cancer…
NEW YORK (Reuters Health) – Results of an integrated analysis of pooled data from two clinical trials confirm that the recombinant peptide ecallantide (Kalbitor; Dyax Corp) reduces symptoms…
NEW YORK (Reuters Health) – Patients undergoing percutaneous coronary interventions who receive high-dose statin treatment before the procedure have about half the rate of major adverse cardiac events…
NEW YORK (Reuters Health) – The combination of etanercept and cyclophosphamide might be a risky one in patients with Wegener’s Granulomatosis, especially with those who have long-term, chronic…
NEW YORK (Reuters Health) – A study from China indicates that vardenafil has favorable effects in patients with pulmonary arterial hypertension (PAH). Dr. Zhi-Cheng Jing, at Tongji University…
